Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Selecting treatment methods for cervical cancer

Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France
Selecting treatment methods for cervical cancer ( Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France )
1 Nov 2013

Results of the ICON7, phase III clinical trial

Prof Eric Pujade-Lauraine - Université de Paris Descartes, France
Results of the ICON7, phase III clinical trial ( Prof Eric Pujade-Lauraine - Université de Paris Descartes, France )
1 Nov 2013

Overview of the 2013 ESGO scientific programme

Prof John Green – University of Liverpool, UK
Overview of the 2013 ESGO scientific programme ( Prof John Green – University of Liverpool, UK )
31 Oct 2013

Treatment guidelines for endometrial cancer and increased rates of incidence

Prof John Green - University of Liverpool, UK
Treatment guidelines for endometrial cancer and increased rates of incidence ( Prof John Green - University of Liverpool, UK )
31 Oct 2013

European Cancer Congress 2013 - News Roundup

Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology
European Cancer Congress 2013 - News Roundup ( Prof Gordon Mcvie - ecancer Managing Editor and the European Institute of Oncology )
22 Oct 2013

Meeting highlights from the 11th iwNHL 2013: Day 2

Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh
Meeting highlights from the 11th iwNHL 2013: Day 2 ( Prof John Gribben, Dr Randy Gascoyne, Dr Wyndham Wilson, Dr Myron Czuczman and Prof Pfreundschuh )
15 Oct 2013

Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan

Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan
Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan ( Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan )
7 Oct 2013

FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA
FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA )
7 Oct 2013

Development of bio-similar drugs

Dr Javier Cortés - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Development of bio-similar drugs ( Dr Javier Cortés - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
4 Oct 2013

Molecular biology guiding treatment of gastrointestinal stromal tumours (GISTs)

Dr Javier Martin-Broto - Son Espases Hospital, Palme de Mallorca, Spain
Molecular biology guiding treatment of gastrointestinal stromal tumours (GISTs) ( Dr Javier Martin-Broto - Son Espases Hospital, Palme de Mallorca, Spain )
4 Oct 2013

Analysis of progression free survival versus overall survival in melanoma

Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA
Analysis of progression free survival versus overall survival in melanoma ( Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA )
3 Oct 2013

New antibody drug, MPDL3280A, in non-small cell lung cancer

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France
New antibody drug, MPDL3280A, in non-small cell lung cancer ( Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France )
3 Oct 2013